BioTech 365

NOVEMBER 3, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bristol Myers Squibb-backed Clade nabs a meaty $87M series A for cell therapy 2.0.Bristol Bristol Myers Squibb-backed Clade nabs a meaty $87M series A for cell therapy 2.0 … Continue reading →

Research 40

Research 40

BioTech 365

NOVEMBER 3, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Protein Brewery raise €22m in Series A. from European Biotechnology – first and foremost in European biotech [link].

Protein 40

Protein Research 40

BioTech 365

JULY 15, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: PAQ Therapeutics emerges with $30M series A for autophagy-based treatments.PAQ Therapeutics emerges with $30M series A for autophagy-based treatments klahucik Wed, 07/14/2021 – 15:05 from FierceBiotech: Biotech … Continue (..)

Research 40

Research 40

BioTech 365

SEPTEMBER 16, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Polyneuron Pharmaceuticals AG extends Series A financing. from European Biotechnology – first and foremost in European biotech [link].

Research 40

Research 40

BioTech 365

AUGUST 12, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility.Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility … Continue reading →

Research 40

Research 40

BioTech 365

JANUARY 20, 2022

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Fresh from $86M series A, Metis poaches Kala CSO to support move into the clinic.Fresh from $86M series A, Metis poaches Kala CSO to support move into … Continue reading →

Research 40

Research 40

BioTech 365

APRIL 29, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Adcendo raises €51M series A round to pursue ‘ideal’ ADC target.Adcendo raises €51M series A round to pursue ‘ideal’ ADC target ntaylor Thu, 04/29/2021 – 08:05 from … Continue reading → (..)

Research 40

Research 40

BioTech 365

FEBRUARY 3, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Italian Enthera Pharma raise €35m in Series A extension. from European Biotechnology – first and foremost in European biotech [link].

Research 40

Research 40

BioTech 365

DECEMBER 1, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Swiss Noema Pharma raises CHF54m in Series A financing. from European Biotechnology – first and foremost in European biotech [link].

Research 40

Research 40

BioTech 365

DECEMBER 7, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series A raise.Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series … Continue reading →

Research 40

Research 40

BioTech 365

APRIL 15, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New name, new board, new focus: AltruBio relaunches with $63M series A.New name, new board, new focus: AltruBio relaunches with $63M series A aarmstrong Wed, 04/14/2021 – … Continue reading →

Research 40

Research 40

BioTech 365

NOVEMBER 3, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Antios, months after series B, raises a further $75M to fuel pursuit of hepatitis B cure.Antios, months after series B, raises a further $75M to fuel pursuit … Continue reading →

Research 40

Research 40

BioTech 365

MARCH 18, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Aktis bags $72M in Novartis, BMS-backed series A to unlock power of radiopharmaceuticals.Aktis bags $72M in Novartis, BMS-backed series A to unlock power of radiopharmaceuticals ntaylor Thu, … Continue reading →

Research 40

Research 40

BioTech 365

APRIL 2, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Alloy Therapeutics nabs a $75M series C to sow more seeds into the biotech ecosystem. Alloy Therapeutics nabs a $75M series C to sow more seeds into … Continue reading →

Research 40

Research 40

BioTech 365

NOVEMBER 3, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pfizer tears up gene therapy timelines, revealing a series of phase 3 delays that end vision of a banner 2022.Pfizer Pfizer tears up gene therapy timelines, revealing a … Continue reading →

Gene Therapy 40

Gene Therapy Gene Research 40

BioTech 365

JULY 2, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eschewing an IPO (for now), Sirnaomics nabs a rare series E worth $105M for next-gen RNA work.Eschewing an IPO (for now), Sirnaomics nabs a rare series E … Continue reading →

RNA 40

RNA Research 40

BioTech 365

APRIL 7, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push.Bayer-backed Metagenomi bumps up series A to $75M as it gears up … Continue reading →

Gene Editing 40

Gene Editing Gene Research 40

BioTech 365

AUGUST 25, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Atavistik Bio secures $60M series A to tackle metabolic diseases, cancers with former Peloton, Blueprint Medicines execs at the helm.Atavistik Bio secures $60M series A to tackle … Continue reading →

Medicine 40

Medicine Research 40

BioTech 365

JANUARY 21, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Plexium bumps up series A by $35M as it battles rivals in the new protein-degradation space.Plexium bumps up series A by $35M as it battles rivals in … Continue reading →

Protein 40

Protein Research 40

BioTech 365

SEPTEMBER 10, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Korro Bio hits the high notes with $91.5M series A to run its OPERA RNA platform.Korro Bio hits the high notes with $91.5M series A to run … Continue reading →

RNA 40

RNA Research 40

Pharma Mirror

AUGUST 28, 2021

ADELAIDE- Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif.

Vaccination 130

Vaccination Vaccine Development Clinical Trials 130

pharmaphorum

OCTOBER 14, 2022

has announced a $168 million Series B financing, led by global venture capital firm General Catalyst, an active investor in the healthcare sector. The Series B financing includes participation from all Series A investors and new investment from Fidelity Management & Research Company and T.

Engineer 93

Engineer Medicine Genome Genomics 93

Drug Discovery World

MARCH 22, 2024

News round-up for 18-22 March by DDW Digital Content Editor Diana Spencer. 30m raised for first-in-class in vivo cell reprogramming platform Biotech Asgard Therapeutics has closed a €30 million Series A financing to support the development of its lead programme, AT-108.

Gene Therapy 52

Gene Therapy In-Vivo FDA Approval Drugs 52

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Ori raised over $100 million in a Series B as announced in January 2022, which Foster says was at the end of this increased funding window. Weathering a storm of uncertainty.

Marketing 324

Marketing Gene Therapy Manufacturing Pharma Companies 324

Camargo

SEPTEMBER 8, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Some Drugs May Require Reclassification to Devices. Genus succeeded in both the District and Appellate courts.

Development 186

Development Regulation Production Drugs 186

Pharmaceutical Technology

DECEMBER 27, 2022

Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced. Tracking the news. Alzheimer’s disease drugs were constantly in the news, and not always for the right reasons. Tracking drug development.

Clinical Trials 306

Clinical Trials Clinical Trials Trials Vaccination 306

Drug Discovery World

APRIL 5, 2024

News round-up for 1-5 April by DDW Digital Content Editor Diana Spencer. R&D partnership to jointly develop new ALS drugs PrecisionLife and the Nucleic Acid Therapy Accelerator (NATA) have announced a collaboration to co-develop novel oligonucleotide therapies for sporadic motor neurone disease/ALS.

Drugs 52

Drugs Life Science Development Research 52

Camargo

OCTOBER 14, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. FDA Discusses Focus Areas for PDUFA VII During Public Meeting. Improved predictability in Human Factors and User-Related Risk reviews.

Development 189

Development Packaging Packaging Generic Drugs 189

BioSpace

APRIL 4, 2021

The news comes months after the company closed a $63 million Series B and inlicensed RAIN-32 from Daiichi Sankyo.

Trials 65

Trials 65

Camargo

NOVEMBER 15, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. It created the possibility of more easily obtaining information to support new product indications or to help with post-approval study requirements.

Development 187

Development Manufacturing Production Packaging 187

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Adding to this, other events like the worldwide energy crisis and the ongoing conflict in Ukraine have led to global uncertainty, Skillington tells this news service.

Marketing 162

Marketing Gene Therapy Manufacturing Pharma Companies 162

World of DTC Marketing

AUGUST 9, 2021

Most HCPs go to Medscape as a “first stop” in the morning to get their healthcare news. million other healthcare professionals worldwide, including medical students, residents, nurses, and more,45 Medscape is the largest news site for HCPs around the world, . Doximity was flagged for having anti-vaccine information.

Nurses 294

Nurses Marketing Pharma Companies Production 294

Camargo

JULY 8, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. At Camargo, we have worked with hundreds of investigators who have found new targets for established drugs.

Development 130

Development Bioequivalency Gene Expression Drugs 130

Drug Discovery World

FEBRUARY 23, 2024

News round-up for 19-23 February by DDW Digital Content Editor Diana Spencer. New data validates tau silencing gene therapy for Alzheimer’s Voyager Therapeutics has announced new data from its two preclinical programmes targeting pathological tau for the treatment of Alzheimer’s disease.

Gene Therapy 52

Gene Therapy Insulin FDA Approval Drugs 52

ACRP blog

SEPTEMBER 13, 2023

The first step involved a series of structured community conversations across Oregon where they gathered a group of community members to have an open conversation about cancer, ranging from general understanding to prevention, early detection, and diagnosis, and on to treatment and survivorship.

Clinical Trials 132

Clinical Trials Clinical Trials Trials Nurses 132

Intouch Solutions

JANUARY 5, 2023

EVERSANA INTOUCH leaders and their insights figured largely in Med Ad News ‘ recent annual Healthcare Agency Roundtable series of articles. On topics that ranged from trends, opportunities, equity and inclusion, resiliency and uncertainty, and more, you can check out our leaders quoted throughout the series!

Marketing 52

Marketing 52

Camargo

JUNE 4, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Since this new product is applied via instillation, Heron bridged from the topically applied product to the systemic data in the public literature.

Development 130

Development Production Drugs Marketing 130